Terbutaline Warning – Do Not Use for Treatment of Preterm Labor
Terbutaline (Brethine, Bricanyl, and Bethaire) was put on the market to prevent and treat asthma, bronchitis and emphysema. However, some healthcare providers have used it for “off-label” treatment.
Terbutaline has been used “off-label” as a fast acting treatment for preterm labor and has been linked to numerous side effects, including birth injuries.
Common birth injuries linked to of Terbutaline, include:
- Brain damage
- Developmental problems
- Birth defects
- Autism (particularly in twin pregnancies)
- Speech and movement defects
Due to this “off-label” use and the dangers involved, the FDA is now requiring a Boxed Warning and Contraindications for this drug. The FDA has notified healthcare professionals that the injectable Terbutaline should not be used on pregnant woman for prevention of prolonged treatment of preterm labor.
Additional Terbutaline side effects are very dangerous and include:
• Increased heart rate
• Transient hyperglycemia (high blood sugar)
• Hypokalemia (low potassium - causes weakness & heart abnormalities)
• Cardiac arrhythmia (irregular heat beat)
• Pulmonary edema (fluid in the lungs)
• Myocardial ischemia (reduced blood supply to the heart)
The FDA has concluded that the risk of serious adverse side effects outweigh any potential benefit to pregnant woman receiving prolonged treatment with Terbutaline injection.
If you or a loved one has been injured after treatment with Terbutaline, contact Cellino & Barnes today for a Free Consultation. 800-621-2020